13G FOR STELLAR

Company

Edesa Biotech, Inc.

Filed

October 30, 2015

Accession Number

0001217160-15-000322

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →